Standards and reference materials for the anticardiolipin and anti-β 2glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 358-360

  Pierangeli, Silvia S ^a   Favaloro, Emmanuel J ^b   Lakos, Gabriella ^c   Meroni, Pier Luigi ^d,e   Tincani, Angela ^f   Wong, Richard C W ^g   Harris, E Nigel ^h  

^a University of Texas Medical Branch School of Medicine   (United States)

^b WESTMEAD HOSPITAL   (Australia)

^c INOVA DIAGNOSTICS INC   (United States)

^d ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^f SPEDALI CIVILI   (Italy)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Anti 2glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Calibrators; Units of measurement

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CALIBRATOR; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; HUMAN; IMMUNOASSAY; LABORATORY TEST; PREGNANCY DISORDER; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; SCIENTIST; STANDARDIZATION; THROMBOSIS; VALIDATION PROCESS; WORKSHOP;

ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CALIBRATION; IMMUNOASSAY; REFERENCE STANDARDS;

EID: 82955173886     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.048     Document Type: Article

References (20)

1. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
2. Harris E.N., Gharavi A.E., Patel S., Hughes G.R.C. Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4 1986. Clin Exp Immunol 1987, 68:215-222.
3. Harris E.N. The second international anticardiolipin standardization workshop: the Kingston Anticardiolipin Antibody Study (KAPS) group. Am J Clin Pathol 1990, 101:616-624.
4. Harris E.N., Pierangeli S., Birch D. Anticardiolipin wet workshop report: Vth international symposium on antiphospholipid antibodies. Am J Clin Pathol 1994, 101:616-624.
5. Pierangeli S.S., Stewart M., Silva L.K., Harris E.N. Report of an anticardiolipin workshop during the VIIth International Symposium on Antiphospholipid Antibodies. J Rheumatol 1998, 25:156-162.
6. Wong R.C.W., Wilson R.J., Pollock W., et al. Anticardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program. Pathology 2004, 36:174-181.
7. Tincani A., Allegri F., Sanmarco M., et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001, 86:575-583.
8. Jennings I., Kitchen S., Woods T.A., et al. Potentially clinically important inaccuracies in testing for lupus anticoagulant: an analysis of results from three survey of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost 1997, 77:934-937.
9. Reber G., Tincani A., Sanmarco M., et al. Proposals for the measurement of anti-β2glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004, 2:1860-1862.
10. Favaloro E.J., Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002, 118:548-557.
11. Derksen W., Erkan D., Kaplan V., et al. Real world experience with antiphospholipid antibodies (APL): how stable are APL over time?. Arthritis Rheum 2004, 50(9):S67. [Abstract].
12. Peaceman A.H., Silver R.K., MacGregor S.N., Scool M.L. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol 1992, 144:1780-1784.
13. Pierangeli S.S., Gharavi M.D., Harris E.N. Testing for antiphospholipid antibodies: problems and solutions. Clin Obstet Gynecol 2001, 44:48-57.
14. Reber Gm, Schousboe I., Tincani A., et al. Inter-laboratory variability of anti b2glycoprotien I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 2002, 88:66-73.
15. Pierangeli S.S., deGroot P.G., Dlott J., et al. "Criteria" aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX. April 2010. Lupus 2011, 20:182-190.
16. Ichikawa K., Tsutsumi A., Atsumi T., et al. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2 glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum 1999, 42:2461-2470.
17. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
18. Forastiero R., Papalardo E., Watkins M., et al. Evaluation of the performance of monoclonal and polyclonal antibody standards in different assays for the detection of antiphospholipid antibodies: report of a wet workshop at the 13th International Congress on Antiphospholipid (aPL) Antibodies. Arthritis Rheum 2010, 62:S946. (suppl).
19. Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004). World Health Organization WHO Technical Report Series, No. 932 2006.
20. Lewis S., Keil L.B., Binder W.L., De Bari V. Standardized measurement of major immunoglobulin class (IgG, IgA and IgM) antibodies to β2glycoprotein 1 in patients with antiphospholipid syndrome. J Clin Lab Anal 1998, 12:293-297.